Institute of Dermatology and Department of Dermatology at No 1 Hospital, Anhui Medical University, Hefei, Anhui, China.
J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1299-303. doi: 10.1111/j.1468-3083.2010.03971.x. Epub 2011 Jan 17.
Human leucocyte antigen (HLA)-II alleles have been found to be associated with vitiligo in different populations, and several studies also suggested that HLA class II alleles/haplotypes were associated with a different type vitiligo. Of HLA class II alleles, DRB1*07 has consistently shown a positive association with vitiligo in Chinese Han population.
To further explore the relationship between DRB107 and vitiligo and to evaluate the DRB107 effect on the clinical features of vitiligo in Chinese Han population.
This study investigated DRB107 allele distribution in 1178 unrelated Chinese vitiligo patients and 1743 healthy controls using polymerase chain reaction/sequence specific primer method and observed clinical differences between DRB107 positive and DRB1*07 negative patients.
The analysis of the 1178 cases and 1743 controls revealed a highly association between DRB107 allele and vitiligo [odds ratio (OR) = 1.97, P = 2.13 × 10(-17) ]. DRB107 positive patients had early disease onset (OR = 1.49, P = 0.001), higher frequency of family history (OR = 1.44, P = 0.006) compared with DRB1*07 negative patients.
The DRB107 showed significant association with vitiligo in the study population. This study confirmed that DRB107 positive patients had some obvious clinical differences from DRB1*07 negative patients in the Chinese Han population.
人类白细胞抗原(HLA)-II 等位基因已被发现与不同人群的白癜风有关,几项研究还表明 HLA Ⅱ类等位基因/单倍型与不同类型的白癜风有关。在 HLA Ⅱ类等位基因中,DRB1*07 在中国汉族人群中与白癜风始终表现出正相关。
进一步探讨 DRB107 与白癜风的关系,并评估 DRB107 对中国汉族人群白癜风临床特征的影响。
本研究采用聚合酶链反应/序列特异性引物法,对 1178 例无关的中国白癜风患者和 1743 例健康对照者的 DRB107 等位基因分布进行了研究,并观察了 DRB107 阳性和 DRB1*07 阴性患者之间的临床差异。
对 1178 例病例和 1743 例对照的分析显示,DRB107 等位基因与白癜风高度相关[比值比(OR)=1.97,P=2.13×10(-17)]。DRB107 阳性患者发病较早(OR=1.49,P=0.001),家族史阳性率较高(OR=1.44,P=0.006)。
DRB107 在研究人群中与白癜风有显著相关性。本研究证实,在中国汉族人群中,DRB107 阳性患者与 DRB1*07 阴性患者相比,具有一些明显的临床差异。